<code id='CE0DC11709'></code><style id='CE0DC11709'></style>
    • <acronym id='CE0DC11709'></acronym>
      <center id='CE0DC11709'><center id='CE0DC11709'><tfoot id='CE0DC11709'></tfoot></center><abbr id='CE0DC11709'><dir id='CE0DC11709'><tfoot id='CE0DC11709'></tfoot><noframes id='CE0DC11709'>

    • <optgroup id='CE0DC11709'><strike id='CE0DC11709'><sup id='CE0DC11709'></sup></strike><code id='CE0DC11709'></code></optgroup>
        1. <b id='CE0DC11709'><label id='CE0DC11709'><select id='CE0DC11709'><dt id='CE0DC11709'><span id='CE0DC11709'></span></dt></select></label></b><u id='CE0DC11709'></u>
          <i id='CE0DC11709'><strike id='CE0DC11709'><tt id='CE0DC11709'><pre id='CE0DC11709'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:knowledge    Page View:5
          Two Vertex buidings in the Seaport District
          David L Ryan/Globe Staff

          When Vertex Pharmaceuticals moved from Cambridge to Boston’s Seaport a decade ago, it signaled that what was then a sea of parking lots could be a booming business district, and galvanized a wave of new development.

          Now, Vertex may be on the move again.

          advertisement

          With the lease on its two-building campus on Fan Pier set to expire in 2028, the company is reevaluating its real estate options — and considering leaving its prominent headquarters for another spot in the neighborhood.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          focus

          ChatGPT in medicine: STAT answers readers' burning questions
          ChatGPT in medicine: STAT answers readers' burning questions

          MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

          read more
          Why Eli Lilly’s earnings didn’t quite live up to the hype
          Why Eli Lilly’s earnings didn’t quite live up to the hype

          KristofferTripplaar/APEventually,theluckiestcompaniesgettodealwithaveryparticularproblem:whattodowhe

          read more
          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more

          Abbott's new heart device gets FDA advisory panel nod

          ThedeviceiscalledtheTriClip,anditaddressesadiseasecalledtricuspidregurgitation:aheartconditionthatca